Abstract
Glioblastoma multiforme (GBM) is a malignant brain cancer that causes high mortality in patients. GBM responds weakly to the common cancer treatments such as chemotherapy and radiotherapy and even surgery. Carboplatin is an alkylating agent widely used to treat cancer. However, resistance to this drug is a common problem in its use in cancer treatment. Concomitant exposure to extremely low-frequency electromagnetic fields (ELF-EMFs) and carboplatin is one unexplored possibility for overcoming this resistance. Indeed, many lines of evidence show that EMF affects cancer cells and drug action. In this study, we evaluated the effect of concomitant administration of carboplatin and EMF (50 Hz, 70 G) and also concomitant administration of carboplatin and static magnetic field (SMF) (70 G) on human glioma cell line (U-87). The results showed that cotreatment reduced the efficiency of carboplatin in U-87 cells, by decreasing caspase-3 in comparison to drug groups. Overall, EMF reduced the apoptotic effect of carboplatin, possibly through a redox regulation mechanism. Therefore, we have to avoid coadministration of magnetic field (MF) and carboplatin in tumor area, because the MF decreased the toxicity of the drug. However, further stud...Continue Reading
References
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Dec 1, 1992·Electroencephalography and Clinical Neurophysiology·G B BellA L Chesson
May 8, 1989·FEBS Letters·A CossarizzaC Franceschi
Aug 15, 1970·Nature·U K Laemmli
Jan 1, 1994·Life Sciences·M A MorandiL D Caren
Sep 1, 1993·Cancer Causes & Control : CCC·B FloderusB Knave
Feb 1, 1993·Experimental Cell Research·A CossarizzaC Franceschi
May 15, 1996·Biochemical and Biophysical Research Communications·W X BalcavageM W King
Jan 1, 1996·Neuropsychobiology·K Mann, J Röschke
Jan 1, 1996·Bioelectromagnetics·R R RaylmanR L Wahl
May 20, 1998·Journal of Toxicology and Environmental Health. Part a·D FlipoK Krzystyniak
Sep 24, 1998·Clinical Neurology and Neurosurgery·L MastronardiA Ruggeri
Jul 26, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D J Vaughn
Apr 5, 2001·Nephron·M BuemiF Corica
Sep 12, 2001·Neuro-oncology·J G Gurney, E van Wijngaarden
Oct 24, 2002·Bioelectromagnetics·M J Ruiz-GómezM Martínez-Morillo
Jun 12, 2003·Gynecologic Oncology·Peter G RoseMichael Rodriguez
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Nov 24, 2004·Progress in Biophysics and Molecular Biology·Richard Saunders
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rameen BeroukhimWilliam R Sellers
May 29, 2014·Journal of Blood Medicine·Kristina M HaleyKellie J Nazemi
Nov 26, 2014·PloS One·Cristian VergalloLuciana Dini
Nov 23, 2016·Electromagnetic Biology and Medicine·Zeinab AkbarnejadMeysam Ahmadi
May 30, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zeinab AkbarnejadMeysam Ahmadi
Citations
Jul 10, 2020·Cancer Biotherapy & Radiopharmaceuticals·Samereh Dehghani-SoltaniMeysam Ahmadi-Zeidabadi
Jul 16, 2020·Electromagnetic Biology and Medicine·Ahmad AshtaMeysam Ahmadi-Zeidabadi
Jun 11, 2019·Electromagnetic Biology and Medicine·Meysam Ahmadi-ZeidabadiHossein Eskandary